<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03248544</url>
  </required_header>
  <id_info>
    <org_study_id>1396-607</org_study_id>
    <nct_id>NCT03248544</nct_id>
  </id_info>
  <brief_title>Therapeutic Benefit of Preoperative Supplemental Vitamin D in Patients Undergoing Brain Tumor Surgery</brief_title>
  <official_title>Effect of Single High Dose Vitamin D3 on Peri-operative and Post-operative Complications and Clinical Outcomes in Patients Under Craniotomy for Brain Tumor Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shahid Beheshti University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitamin D supplementation not only has beneficial effects on morbidity and mortality in
      critically ill patients but it may also lead to alleviate of seizure, brain edema, infection,
      pain and some other perioperative complications, possibly in part through an attenuation of
      the immune response.In this trial patients with brain tumor under craniotomy will receive a
      single high dose vitamin D compared to control group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized, double blind, controlled trial will be conducted in neurosurgery ward,
      operating room (OR) and intensive care unit (ICU) in Tehran, Iran. After a full review of the
      inclusion and exclusion criteria and explanation of the risks and benefits of the study,
      written consent form will be completed. The participants are 60 eligible hospitalized
      patients that diagnosed with brain tumor and need to craniotomy, aged â‰¥ 18 years.
      Intervention patients will be received an intramuscular (IM) single dose of vitamin D (300000
      IU). Patients will be evaluated for occurrence of perioperative complications and clinical
      outcomes immediately after surgery until 1 month later and 1 and 6 months mortality.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 6, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vitamin D level</measure>
    <time_frame>Postoperative day 5</time_frame>
    <description>25(OH) will be measured after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peri-operative Complications</measure>
    <time_frame>During surgery, recovery and hospitalization (5 days post op)</time_frame>
    <description>Complications in operating room, recovery room, ICU and neurosurgery ward</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative Complications</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Complications after hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of stay in ICU</measure>
    <time_frame>30 days</time_frame>
    <description>Length of stay in ICU is measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of stay in hospital</measure>
    <time_frame>30 days</time_frame>
    <description>Length of stay in hospital is measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1-month mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Mortality during hospitalization or 1 month after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6-month mortality</measure>
    <time_frame>6 months</time_frame>
    <description>Mortality during 6 months after surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Brain Neoplasms</condition>
  <arm_group>
    <arm_group_label>vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention patients will be received a single dose of 300000 IU vitamin D via intramuscular injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Control patients will not be received any intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>vitamin D</intervention_name>
    <description>Fat-soluble vitamin D injection contain of 300,000 IU vitamin D that given via intramuscular injection</description>
    <arm_group_label>vitamin D</arm_group_label>
    <other_name>Cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control</intervention_name>
    <description>No intervention</description>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent of patient or legal representative

          -  25(OH)D level below 20ng/dL

        Exclusion Criteria:

          -  Other trial participation, including previous participation in the pilot trial

          -  Pregnant or lactating women

          -  Hypercalcemia

          -  Hyperphosphatemia

          -  Tuberculosis

          -  Sarcoidosis

          -  History of nephrolithiasis

          -  History of hyperparathyroidis

          -  Medications that interfere with vitamin D metabolism

          -  Renal Insufficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zahra Vahdat Shariatpanahi, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zahra Vahdat Shariatpanahi, MD, PhD</last_name>
    <phone>00989122038186</phone>
    <email>nutritiondata@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zahra vahdat shariatpanahi, MD, PhD</last_name>
      <phone>00989122038186</phone>
      <email>nutritiondata@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shohada Tajrish Hospital</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zahra Vahdat Shariatpanahi, MD.PhD</last_name>
      <email>nutritiondata@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2017</study_first_submitted>
  <study_first_submitted_qc>August 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2017</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shahid Beheshti University</investigator_affiliation>
    <investigator_full_name>Zahra Vahdat Shariatpanahi</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>vitamin D</keyword>
  <keyword>Brain Neoplasms</keyword>
  <keyword>perioperative complications</keyword>
  <keyword>clinical outcomes</keyword>
  <keyword>craniotomy</keyword>
  <keyword>Immune System</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Neoplasms</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

